| Trial ID: | L4373 |
| Source ID: | NCT01704417
|
| Associated Drug: |
Insulin Degludec
|
| Title: |
A Trial Comparing the Effect of Exercise on Blood Glucose in Subjects With Type 1 Diabetes, Who Are Treated With Either Insulin Degludec or Insulin Glargine
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1
|
| Interventions: |
DRUG: insulin degludec|DRUG: insulin glargine
|
| Outcome Measures: |
Primary: BGpre-exe - BGminimum,exe, difference between blood glucose concentration before exercise and the minimum blood glucose concentration observed during exercise, From 0 to 30 minutes | Secondary: BGmean,exe, mean blood glucose concentration during exercise, From 0 to 30 minutes|BGmean,30-180min,post-exe, mean blood glucose concentration, Between 30 and 180 minutes, i.e. post-exercise|BGminimum,30-180min,post-exe, minimum blood glucose concentration, Between 30 and 180 minutes, i.e. post-exercise
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2012-10
|
| Completion Date: |
2013-03
|
| Results First Posted: |
|
| Last Update Posted: |
2016-12-16
|
| Locations: |
Novo Nordisk Investigational Site, Neuss, 41460, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT01704417
|
